Pharma Commercial Mock
IQVIA
Connected Intelligence™
National Prescription Audit
Source: NPA Weekly · Refresh: 2026-05-29·Marten Veskimae
Brand-level trends · ZENVARA

Weekly NPA dashboard · west

TRx (week)
491 0.6%
vs WK28, 2026-05-29
NRx (week)
150 2.6%
vs prior week
NBRx (week)
30 9.1%
new-to-brand
Cumulative TRx
6,480
12-week window
📈TRx — plan vs actual
024849574303-1303-2704-1004-2405-0805-22
Plan Actual
📊NRx ⨉ NBRx trend
03-1303-2704-1004-2405-0805-22
NRx NBRx
🍩Channel mix
RETAIL31%MAIL61%LTC8%
🗺️Geography — variance vs plan
WestMidwestNortheastSoutheast
Variance vs plan — darker = worse. Northeast highlighted as primary deviation region.
Weekly detail · 12 weeks
Week EndingTRxNRxNBRxPlan TRxVar %Cum TRx
2026-03-1360218449669-10.0%602
2026-03-2056117447670-16.3%1,163
2026-03-2756917944671-15.2%1,732
2026-04-0352114937672-22.5%2,253
2026-04-1059217542673-12.0%2,845
2026-04-1754116036673-19.6%3,386
2026-04-2459118340674-12.3%3,977
2026-05-0150315034674-25.4%4,480
2026-05-0851315434674-23.9%4,993
2026-05-1550214531674-25.5%5,495
2026-05-2249415433675-26.8%5,989
2026-05-2949115030675-27.3%6,480
© 2026 IQVIA. All rights reserved. IQVIA® is a registered trademark of IQVIA Inc. in the United States, the European Union and various other countries. NPA™, Xponent™ and Connected Intelligence™ are trademarks of IQVIA Inc. This view is a demo mock and is not affiliated with IQVIA.